489 related articles for article (PubMed ID: 15719729)
1. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
2. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
3. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
Urologiia; 2000; (3):22-4. PubMed ID: 11186703
[TBL] [Abstract][Full Text] [Related]
4. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
[TBL] [Abstract][Full Text] [Related]
5. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
6. [Results of organ-preserving therapy for invasive bladder cancer].
Matveev BP; Figurin KM; Toktomushev AT
Urologiia; 2002; (3):3-5. PubMed ID: 12180056
[TBL] [Abstract][Full Text] [Related]
7. Organ-sparing treatment in muscle-invasive bladder cancer.
Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
[TBL] [Abstract][Full Text] [Related]
8. [Endoscopic operations in invasive cancer of the urinary bladder].
Martov AG; Chernyshev IV; Sysoev PA; Gushchin BL; Shapovalov VV; Kozlov VV; Kornienko SI
Urologiia; 2005; (2):35-9. PubMed ID: 15989025
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer].
Danil'chenko DI; Koenig F; Riedl K; Schnorr D; Waldman A; Al-Shukri S; Loening SA
Vopr Onkol; 2003; 49(6):734-7. PubMed ID: 14976918
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
[TBL] [Abstract][Full Text] [Related]
11. Transurethral resection of non-muscle-invasive bladder transitional cell cancers with or without 5-aminolevulinic Acid under visible and fluorescent light: results of a prospective, randomised, multicentre study.
Schumacher MC; Holmäng S; Davidsson T; Friedrich B; Pedersen J; Wiklund NP
Eur Urol; 2010 Feb; 57(2):293-9. PubMed ID: 19913351
[TBL] [Abstract][Full Text] [Related]
12. [Fluorescence diagnosis in patients with non-muscle invasive bladder cancer: results of a metaanalysis].
Kausch I; Sommerauer M; Montorsi F; Stenzl A; Jacqmin D; Jichlinski P; Jocham D; Ziegler A; Vonthein R
Aktuelle Urol; 2010 May; 41(3):171-7. PubMed ID: 20486035
[TBL] [Abstract][Full Text] [Related]
13. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
14. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of bladder cancer].
Lopatkin NA; Darenkov SP; Chernyshev IV; Martov AG; Stupak NV
Urologiia; 2004; (1):12-7. PubMed ID: 15022437
[TBL] [Abstract][Full Text] [Related]
16. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
Karaguzhin SG; Merinov DS; Martov AG
Urologiia; 2005; (5):17-21. PubMed ID: 16281833
[TBL] [Abstract][Full Text] [Related]
17. [Bladder preservation for locally advanced bladder cancer by transurethral resection, systemic chemotherapy and radiation].
Honda M; Satoh M; Tujimoto Y; Takada T; Matsumiya K; Fujioka H
Hinyokika Kiyo; 2006 May; 52(5):331-5. PubMed ID: 16758720
[TBL] [Abstract][Full Text] [Related]
18. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
19. [Value of the photodynamic method in the diagnosis of superficial bladder tumors].
Lipiński MI; Jeromin LM
Wiad Lek; 2004; 57 Suppl 1():192-5. PubMed ID: 15884237
[TBL] [Abstract][Full Text] [Related]
20. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]